Ki Jun Jeong Promoted to Associate Professor with Tenure at Kaist

Congratulations to alum Dr. Ki Jun Jeong on his promotion to Associate Professor with Tenure at KAIST! http://proteineng.cafe24.com/xe/

Undergraduate Researcher Ahlan Qerqez Accepted to UT CHE

Congratulations to Ahlam Qerqez who has been accepted to the graduate program at UT Austin in the Chemical Engineering Department. Ahlam will join alum Jennifer Maynard’s lab. https://sites.google.com/site/maynardlabatut/Home

Giulia Agnello Graduates and Accepts Position at Anglea Biotechnology, INC

Congratulations to Giulia Agnello for successfully defending her thesis, “Development of Human Enzymes for Amino Acid Depletion Therapy,” April 2016. Giulia has accepted a Research Scientist position at Aeglea Biotherapeutics, Inc.

Navin Varadarajan Promoted to Associate Professor

Congratulations to alum Dr. Navin Varadarajan on being promoted to Associate Professor at University of Houston! http://singlecell.chee.uh.edu/

Congratulations!

Anthrax Treatment Engineered by Texas CHE Researchers Gains FDA Approval

Researchers at The University of Texas at Austin, including Texas ChE’s Dr. George Georgiou and Dr. Jennifer Maynard, successfully culminated years of work when a drug they engineered for the treatment and prevention of inhalational anthrax — the anthrax antitoxin obiltoxaximab — received approval March 21 from the U.S. Food and Drug Administration (FDA). Part of the molecule was engineered at UT Austin before being licensed to New Jersey-based pharmaceutical company Elusys Therapeutics for further development. It will be sold under the name Anthim.

https://che.utexas.edu/2016/04/04/anthrax-treatment-engineered-texas-che-researchers-gains-fda-approval/

Dr. Georgiou Elected to the National Academy of Inventors